Book Chapters
1. 1. Discovery of Hepatitis Viruses and two Nobel prizes: atale of keen observations, serendipity, collaborative research, astuteinterpretations and game-changing innovations. Translational BiomedicalSciences. 2021
2. 2. Managing NASH on a long term basis Current andemerging therapies. Progress in Gastroenterology and Hepatology, ISG 2019
3. 3. Non-alcoholic Fatty Liver Disease (NAFLD)- How Do I Manage?Progress in Gastroenterology and Hepatology, ISG 2018
4. 4. Non-Cirrhotic Portal Hypertension (Including EHPVO, NCPF,HVOTO), API Textbook of Medicine, 11th Edition
5. 5. Non-alcoholic Fatty Liver Disease: Indian Scenario, APIMedicine Update 2015
6. 6. Hepatitis C Virus: An Update in Management, APIMedicine Update 2015
Published Articles
1. 1. De A, Kumari S, Singh A, Kaur A, Sharma R, BhallaA, Sharma N, Kalra N, Singh V. Multiple Cycles of GranulocyteColony-Stimulating Factor Increase Survival Times of Patients WithDecompensated Cirrhosis in a Randomized Trial. Clin Gastroenterol Hepatol. 2021;19(2):375-383.e5.doi: 10.1016/j.cgh.2020.02.022.
2. 2. De A, Duseja A.Non-alcoholic Fatty Liver Disease and Obesity. J Postgrad Med Edu Res.2020;XX(X):1-9 (ahead of print)
3. De A, Chawla YK.Nobel Prize in Medicine 2020: Acknowledging the Discovery of Hepatitis C Virus.Annals of the National Academy of Medical Sciences. Annals of the National Academy of Medical Sciences (India). 2020;56(04): 189-190. DOI: 10.1055/s-0040-1722381
4. De A, Ray D, Lamoria S, Sharma V, Khurana TR.Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indianpatients with cirrhosis. JGH Open. 2020;4(5):945-949. doi: 10.1002/jgh3.12369.
5. De A, Duseja A. Natural History of Simple Steatosisor Nonalcoholic Fatty Liver. J Clin Exp Hepatol. 2020;10(3):255-262. doi:10.1016/j.jceh.2019.09.005.
6. De A, Mitra S, Chowdhury A. Epidemiology ofnon-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol.2020;5:16. doi: 10.21037/tgh.2019.09.08.
7. De A, Chawla YK.Two-Dimensional Shear Wave Elastography: Promises for The Future. AME Med J.2017;2:121. doi:10.21037/amj.2017.08.14
8. De A, Lamoria S, Dhawan S, Agarwal S, Sharma V.Duodenal tuberculosis: dig deep to diagnose. Trop Doct. 2016;46(3):172-4. doi:10.1177/0049475515613921.
9. De A, Singh A, Kumari S, Singh V. Has the time comefor using MELD-Sarcopenia score? J Hepatol. 2018 Jun;68(6):1324. doi:10.1016/j.jhep.2018.01.041.
10. Goel R,Roy A, Ray D, Chaluvashetty SB, De A. A case of amoebic liver abscesscomplicated by bilhaemia and venous thrombosis. Trop Doct. 2020 Dec6:49475520975948. doi: 10.1177/0049475520975948
11. SinghI, De A, Singh V. Transition of AKI to CKD in cirrhosis - effect ofbaseline eGFR and unanswered questions. J Hepatol. 2020 Sep;73(3):737-738. doi:10.1016/j.jhep.2020.03.022
12. MehtaniR, De A, Singh V. Letter: HRS-AKI - a frequent misdiagnosis in thereal-world setting? Aliment Pharmacol Ther. 2020;52(6):1090-1091. doi:10.1111/apt.15964
13. SinghA, De A, Singh V. Post-transplant malignancies in alcoholic liverdisease. Transl Gastroenterol Hepatol. 2020;5:30. doi: 10.21037/tgh.2019.11.18.
14. Soni D,Roy A, De A, Verma N, Singh V. MASQ-HE: Unmasking the Predictors ofOvert Hepatic Encephalopathy? Am J Gastroenterol. 2020 Oct 19. doi:10.14309/ajg.0000000000001010. Epub ahead of print.
15. DusejaA, De A, Taneja S, Choudhury AK, Devarbhavi H, Hu J, et al; APASL ACLFWorking Party, APASL ACLF Research Consortium (AARC). Impact of metabolic riskfactors on the severity and outcome of patients with alcohol-associatedacute-on-chronic liver failure. Liver Int. 2021;41(1):150-157. doi:10.1111/liv.14671.
16. Nada R,Sekar DA, Arpitha DK, De A, PH, PD. Acute-on-chronic Liver Failure in a YoungGirl. J Postgrad Med Edu Res 2020; 54 (1):20-23.
17. Roy A, DeA, Singh V. DAAs and HBV/HCV coinfection: Glimmer of light and a few shadesof grey. J Hepatol. 2020;73(2):461. doi: 10.1016/j.jhep.2020.03.010
18. Sharma V, Lamoria S, Dhawan S, De A, Lamba BMS. Use of gastroscope forevaluation and treatment of lesions in the proximal jejunum. Arq Bras Cir Dig.2019;32(2):e1446.
19. Sharma V, Lamoria S, De A, Agarwal S, Lamba BMS. Endoscopicdiagnosis of duodenal tuberculosis: A case series. Tropical gastroenterology:official journal of the Digestive Diseases Foundation. 2019;38(3):176-8
20. TanejaS, Duseja A, Mehta M, De A, Verma N, Premkumar M, Dhiman RK, Singh V,Singh MP, Ratho RK, Ramachandran R, Kumar V, Kohli HS. Sofosbuvir andVelpatasvir combination is safe and effective in treating chronic hepatitis Cin end-stage renal disease on maintenance hemodialysis. Liver Int. 2020. doi:10.1111/liv.14685
21. Premkumar M, Mehtani R, Divyaveer S,Kajal K, Kulkarni AV, Ahmed S, et al. Clinical Validation of Global CoagulationTests to Guide Blood Component Transfusions in Cirrhosis and ACLF. J ClinTransl Hepatol. Published online: Feb 18, 2021. doi: 10.14218/JCTH.2020.00121.
22. SinghA, Kumari S, Kumar P, De A, Singh V. Sofosbuvir with NS5A inhibitors inhepatitis C virus infection with severe renal insufficiency. J Viral Hepat.2018;25(12):1501-1506. doi: 10.1111/jvh.12983.
23. TanejaS, Duseja A, De A, Mehta M, Ramachandran R, Kumar V, Kohli HS, Gupta KL,Dhiman RK, Chawla Y. Low-Dose Sofosbuvir Is Safe and Effective in TreatingChronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage RenalDisease. Dig Dis Sci. 2018;63(5):1334-1340. doi: 10.1007/s10620-018-4979-6.
24. VermaN, Kaur A, Sharma R, Bhalla A, Sharma N, De A, Singh V. Outcomes aftermultiple courses of granulocyte colony-stimulating factor and growth hormone indecompensated cirrhosis: A randomized trial. Hepatology. 2018;68(4):1559-1573.doi: 10.1002/hep.29763.
25. TanejaS, Duseja A, De A, Kumar V, Ramachandran R, Sharma A, Dhiman RK, GuptaKL, Chawla Y. Successful treatment of chronic hepatitis C infection withdirectly acting antivirals in renal transplant recipients. Nephrology(Carlton). 2018;23(9):876-882. doi: 10.1111/nep.13109.
26. SharmaV, De A, Lamoria S, Lamba BMS. A Vanishing Gastric Submucosal Lesion.Oman Med J. 2017 May;32(3):259-260. doi: 10.5001/omj.2017.49.
27. LamoriaS, De A, Sharma V. Image Diagnosis: Unusual Cause of GastrointestinalBleeding in a Young Man: Isolated Gastric Angiodysplasias. Perm J.2017;21:16-094. doi: 10.7812/TPP/16-094.
28. SharmaV, De A, Lamoria S, Lamba BMS. Black Esophagus:Acute Esophageal Necrosis Due to Alcohol Intoxication. TropicalGastroenterology 2017;38(1):47-48. DOI: http://dx.doi.org/10.7869/tg.391
29. SharmaV, Lamoria S, De A, Lamba BM. Gastrostomy tube replacement by endoscopiccannulation of a narrowed previous tube site. Trop Doct. 2016;46(4):245-246.doi: 10.1177/0049475515624858.
30. LamoriaS, De A, Agarwal S, Singh Lamba BM, Sharma V. Peptic esophagealstricture in an adolescent with Barrett's esophagus. Int J Adolesc Med Health.2016;29(5):/j/ijamh.2017.29.issue-5/ijamh-2015-0106/ijamh-2015-0106.xml. doi:10.1515/ijamh-2015-0106.
31. SharmaV, De A, Ahuja A, Lamoria S, Lamba BM. Acute Esophageal Necrosis Causedby Candidiasis in a Patient with Systemic Lupus Erythematosus. J Emerg Med.2016 Jul;51(1):77-9. doi: 10.1016/j.jemermed.2016.04.005.
32. Lamoria S, De A, Agarwal S,Lamba BM, Sharma V. Postoperative elevation in liver enzymes: an unusual cause.Public Health Emerg 2016;1:22. doi: 10.21037/phe.2016.08.01
33. SharmaV, De A, Lamoria S, Lamba BM. Baclofen-responsive hiccups afteresophageal stenting for malignancy-related dysphagia. Proc (Bayl Univ MedCent). 2016 Apr;29(2):150. doi: 10.1080/08998280.2016.11929394.
34. SharmaV, Gupta H, Lamoria S, De A. Tale of a hairy tail: Rapunzel Syndrome.Intern Emerg Med. 2016 Aug;11(5):759-60. doi: 10.1007/s11739-015-1332-3.
35. Aggarwal P, De A, Dev N, RehaniV, Gadpayle A, Yadav S. Changing Trendsin Malaria. J Trop Dis. 2013;1:124. doi: 10.4172/2329-891X.1000124
Conference Presentations
1. - APICON 2013 Poster presentation: "Enigmatic Case ofAcrocyanosis"
2. - APICON 2014 Poster presentation: "An Unusual Case ofKala Azar Without Splenomegaly"
3. - ISGCON 2015 GE clinics: "Hue Is Half-A-Clue"
4. - INASL 2016 Poster presentation: "SuccessfulTreatment of Chronic Hepatitis C Infection with Directly Acting Antivirals inRenal Transplant Recipients"
5. - ISGCON 2017 Clinics in Liver Disease: An Unusual Case ofACLF In an Immunocompromised Patient
6. - EASL 2017 Poster presentation: New Classification ofGastric Varices: A Twenty-Year Experience
7. - AASLD 2017-
i) Poster presentation: Low Dose Sofosbuvir Is Safe andEffective in Treating Chronic Hepatitis C in Patients with Severe RenalImpairment or End Stage Renal Disease
ii) Poster presentation: Sofosbuvir With NS5A Inhibitors in Hepatitis C Virus InfectedPatients with Severe Renal Insufficiency
iii) Poster presentation: Direct Acting Antivirals inHepatitis C Virus Genotype 3 and Advanced Cirrhosis
iv) Poster presentation: Sarcopenia in DecompensatedCirrhosis
8. - AASLD 2018-
i) Oral presentation: Efficacy of Induced HematopoieticStem Cell Based Therapy in Decompensated Cirrhosis: An Open Label, RandomizedControlled Trial
ii) Poster presentation: Muscle Mass and Muscle Strength inDecompensated Cirrhosis: Correlation and Cut-Offs
iii) Poster presentation: Prevalence of Metabolic RiskFactors and Its Impact on the Severity and Outcome of Patients with AlcoholRelated Acute-on-Chronic Liver Failure a Case Control Study from the APASL AclfResearch Consortium Data Base
iv) Oral presentation: Growth Hormone Therapy in DecompensatedCirrhosis: A Randomised Pilot Study
8. - AASLD 2019 Poster presentation- Long term outcome ofpatients with decompensated cirrhosis treated with multiple cycles of G-CSF.
9. - AASLD 2020
i) Histology of alcoholic hepatitis in acute on chronicliver failure (HALF) study: a preliminary report
ii) Fibroscan AST (FAST) score for non alcoholicsteatohepatitis (NASH) validation in an Indian cohort
iii) Prognostic value of urinary neutrophil gelatinaseassociated lipocalin in HRS AKI